Abstract:AIM:To explore the therapeutic effect of dexamethasone Angelica sinensis polysaccharide prodrug(DEX-AP) on trinitrobenzene sulfonic acid(TNBS) induced ulcerative colitis(UC) in rats and its side effects.METHODS: The experimental UC rats were induced by clusis of the solution of TNBS in 45% alcoho1(50(mg·ml~(-1))).The UC rats were orally administrated with(0.25)(μmol·kg~(-1)·d~(-1)) DEX and(0.05),(0.25),(1.25)(μmol·kg~(-1)·d~(-1)) DEX-AP(calculated by carried DEX in DEX-AP) for 7 days,respectively.The rats were killed after the amount of peripheral blood lymphocyte was counted,then the spleen,thymus and colon were separated and weighted.After the ulcerative area of colon was calculated,the colonic myeloperoxidase(MPO) activity was determined and parts of colon were paraffin sectioned and examined under light microscope by HE stain.RESULTS: After the UC rats were administrated with different doses of DEX-AP for 7 days,the ulcerative area,the weight and the MPO activity of colon reduced significantly.The reduction of MPO activity was correlated to the dose of DEX-AP and the MPO activity with DEX-AP at the doses of(0.25),(1.25)(μmol·kg~(-1)·d~(-1)) reduced more significantly than that with DEX at the the dose of(0.25)(μmol·kg~(-1)·d~(-1)).The number of peripheral blood lymphocyte,spleen weight and thymus weight of UC rats reduced significantly at the dose of(0.25)(μmol·kg~(-1)·d~(-1)) DEX(P(0.01),compared with control group).DEX-AP showed no significant effect on the number of peripheral blood lymphocyte,spleen weight and thymus weight of UC rats at the doses of(0.05),(0.25)(μmol·kg~(-1)·d~(-1)).With the administration of(1.25)(μmol·kg~(-1)·d~(-1)) DEX-AP to UC rats,the structure of the colonic mucosal tissue almost recovered.CONCLUSION: DEX-AP has significant therapeutic effect on TNBS induced UC rats and it has no obvious side effects,thus it indicates a great potential in treating UC.

Colon-targeted Delivery System of Dexamethasone-Angelica Sinensis Polysaccharides Prodrug in Rats

A New Natural Angelica Polysaccharide Based Colon-Specific Drug Delivery System

Synthesis of an Enzyme—dependent Prodrug and Evaluation of Its Potential for Colon Targeting

Synthesis and Delivery Characteristics of Colon-Specific Dexamethasone Prodrug

Pharmacokinetics of colon-specific delivery of dexamethasone prodrug

[Study on the Enzyme Dependant Colon Targeting Prodrug--dexamethasone Succinate Dextran and Its Tablets].

The Investigation of a Prednisolone Prodrug for Colon-Specific Drug Delivery

[Pharmacokinetics of Site-Specific Delivery of Dexamethasone-Dextran Prodrug in Rat Gastrointestinal Tract].

Effect of Dexamethasone Angelica Sinensis Polysaccharide Prodrug on Trinitrobenzene Sulfonic Acid Induced Ulcerative Colitis in Rats

Delivery of Glucocorticoid Conjugate in Rat Gastrointestinal Tract and Its Treatment for Ulcerative Colitis.

Investigation of the Colon-Targeting, Improvement on the Side-Effects and Therapy on the Experimental Colitis in Mouse of a Resin Microcapsule Loading Dexamethasone Sodium Phosphate.

Colon-specific delivery release mechanism of prednisolone-dextran prodrug

Determination of the Loading Amount of Dexamethasone in Dexamethasone-Angelica Sinensis Polysaccharide Prodrugs

Immunomodulation of Rheum tanguticum polysaccharide (RTP) on the immunosuppressive effects of dexamethasone (DEX) on the treatment of colitis in rats induced by 2,4,6-trinitrobenzene sulfonic acid

Hyaluronic Acid Modified Oral Drug Delivery System with Mucoadhesiveness and Macrophage-Targeting for Colitis Treatment.

Synthesis and Characterization of Azo-Containing Dextran Hydrogels as Carriers for Colonic Drug Targeting

Design of colon-targeted drug delivery of dexamethasone: Formulation and in vitro characterization of solid dispersions

Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides.

Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis

Colon-targeted Oral Nanoparticles Based on ROS-scavenging Hydroxyethyl Starch-Curcumin Conjugates for Efficient Inflammatory Bowel Disease Therapy.

Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.